Csenge Advisory Group’s ICU Medical ICUI Stock Holding History

Csenge Advisory Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	–	–	767
2018 Q3	$0	Buy	+3	New	+$879	﹤0.01%	1287

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Csenge Advisory Group's ICUI Position: Q4 2018 in Review

Csenge Advisory Group sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 3 shares.

Csenge Advisory Group first reported a position in ICUI in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Csenge Advisory Group reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 3 ICU Medical shares in Q4 2018.
Csenge Advisory Group first reported a position in ICU Medical in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's ICU Medical position peaked at $0 in Q3 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.